FDA’s Amy Abernethy Transitions to Google’s Verily

Amy Abernethy recently stepped down from her position as principal deputy commissioner for the Food and Drug Administration, where she pushed for the use of real world evidence (RWE). She has since accepted a role leading the clinical research and development division at Google’s Verity.

Verily CEO and Founder Andy Conrad remarks, “There is no one better positioned to catapult Verily’s clinical research business into its next important phase than Amy, with her understanding of clinical practice, research, data science and the evolving regulatory environment.” Read more here.

(Source: Zachary Brennan, Endpoints News, 6/3/21)